DiaSorin Company Research & Development Immunodiagnostic Solutions Molecular Solutions People Culture Investor Relations Research & Development Immunodiagnostics Clinical Areas and Technology Innovation Enter http://www.diasorin.com/en/research-development/clinical-areas-0 Molecular Diagnostics Clinical Areas and Technology Innovation Enter http://www.diasorin.com/en/research-development/clinical-areas Publications Immunodiagnostics Papers and posters Browse and download http://www.diasorin.com/en/research-development/immunodiagnostics/papers About Us Our R&D mission Regularly delivering high quality and innovative tests to fuel product pipeline http://www.diasorin.com/en/research-development/about-us/rd-data-and-investment Publications Molecular Diagnostics Papers and posters Browse and download http://www.diasorin.com/en/research-development/conferences/molecular-diagnostic... Research & Development Immunodiagnostics Molecular Diagnostics About us Contacts Search form Search English Italiano DiaSorin S.p.A. - Share Capital € 55.948.257 R.E.A. 180729 Fiscal Code and Subscription to Vercelli Companies Register no 13144290155 Legal Notices Privacy Policy Modern Slavery Act Statement Scroll down ▼ close Android Iphone